Detected for the first time in 2011, Schmallenberg virus (SBV) is an orthobunyavirus of the Simbu serogroup that caused a large outbreak in European ruminants. In a tight time frame, data have been obtained on SBV epidemiology and the clinical pictures associated with this new viral infection, but little information is available on the molecular biology of SBV. In this study, SBV sequence variability was characterized from the central nervous system of two stillborn lambs in a naturally infected herd. A hypervariable region (HVR) was detected in the N-terminal region of the SBV Gc glycoprotein through sequencing and analysis of the two full-length genomes representative of intra-herd SBV dissemination. In vitro growth assays coupled with full-length genome sequencing were performed on the two isolates after successive cellular passages, showing an in vitro adaptation of SBV and mutation accumulation inside the HVR in the absence of immune selective pressure.
A new virus, Schmallenberg virus (SBV) was identified in
Germany at the end of the summer of 2011 . SBV infection has been detected in a wide range of domestic and wild ruminants in Europe (Beer et al., 2013) . In adult cattle and sheep, it is responsible for an acute but short febrile illness. The major consequence is due to the ability of SBV to cross the placental barrier at a critical gestation stage and cause severe congenital malformations such arthrogryposis and nervous system defects, leading to death before or at birth. Following the recent outbreak caused by bluetongue virus introduced into Europe in 2006, this novel emerging pathogen is the second arbovirus (arthropod-borne virus) causing economic losses to the European ruminant livestock to be discovered in the last 5 years (Saegerman et al., 2011) .
The causative agent is a negative-sense ssRNA virus belonging to the genus Orthobunyavirus of the family Bunyaviridae, which contains numerous pathogens of medical and veterinary importance. The SBV genome is composed of three segments, large (L), medium (M) and small (S), whose coding capacity and proteins have been predicted by analogy with related orthobunyaviruses (Walter & Barr, 2011) . The L segment directs expression of a unique large virion-associated protein with RNAdependent RNA polymerase activity (Jin & Elliott, 1991; Obijeski et al., 1976) . The M segment encodes a polyprotein precursor comprising the two envelope glycoproteins (Gn and Gc) and a non-structural protein (NSm) in a single ORF (in the order Gn-NSm-Gc) (Fuller & Bishop, 1982; Gentsch & Bishop, 1979) . The S segment encodes two polypeptides, the nucleocapsid protein (N) and a non-structural protein (NSs) in overlapping ORFs . The role of SBV proteins remains to be confirmed, but recent data have shown that the SBV NSs protein functions at least as an interferon antagonist, as in other orthobunyaviruses (Elliott et al., 2012; Varela et al., 2013) .
Since the recent identification of SBV, compelling data have been gathered regarding the virus epidemiology (Garigliany et al., 2012; Méroc et al., 2013) , host range (Beer et al., 2013; Linden et al., 2012) , vectors involved in transmission (De Regge et al., 2012; Rasmussen et al., 2012) , damage associated with infection (Bilk et al., 2012; Saegerman et al., 2013) and putative genetic origin of the virus Yanase et al., 2012) . Apart from the description of SBV NSs properties (Elliott et al., 2012; Varela et al., 2013) , little information is available on the molecular biology of SBV. In the present study, we have reported on the mapping of SBV sequence variability in different situations. First, two SBV full-length sequences were analysed from the central nervous system (CNS) of two distinct sheep foetuses naturally infected with SBV. Secondly, the genotypes and phenotypes of these isolates were studied following cell adaptation by successive cellculture passages.
With the aim of characterizing the in vivo SBV variability, two SBV full-length sequences were obtained from the SBV-infected CNS of two different lambs born in January 2012 within the same sheep flock in Belgium. For both samples, SBV-12-Na1 (Na1) and SBV-12-Na2 (Na2) (Na for the city of Namur), total RNA was extracted from the CNS using TRI Reagent (Ambion). The RNA was reverse transcribed using Superscript III (Invitrogen) with specific primer(s) for each segment (Table S1 , available in JGV Online). The PCR primers (Table S1 ) were designed to encompass the whole viral genome into 13 overlapping fragments (one for S, five for M and seven for L; Fig. 1a) . cDNA was amplified by PCR and nested PCR. The resulting amplicons were inserted into a pGEM-T Easy vector (Promega). Five clones of each fragment were sequenced (GATC Biotech) to generate the cDNA sequences of Na1 and Na2 from overlapping fragments (see Table S2 for GenBank accession numbers). We used similarity plot analysis with Simplot software (Lole et al., 1999) to compare the full-length genomes of Na1 with Na2 (Fig. 1b) . In addition, the Na1 and Na2 sequences were each compared with the reference SBV genome derived from the prototype SBV BH80/11-4 strain (Fig. 1c, d ). The plot analysis showed that the mutations were not evenly distributed, as the percentage similarity between the SBV samples differed throughout the genomes. In the three comparisons, a high Similarity plots based on the aligned genome sequences between Na1 and Na2 (b), Na1 and SBV BH80/11-4 (c) and Na2 and SBV BH80/11-4 (d). The hypervariable region (HVR) is shaded. The similarity plots were generated by Simplot and each point plotted is the percentage identity within a 100 nt sliding window centred on the position plotted, with a step size between points of 10 nt.
density of mutations was found within a specific region of the M segment, whereas few mutations were detected in the remaining part of the genome within the S, L and M segments. More precisely, these nucleotide substitutions accumulated in the region of the M segment spanning nt 1394-2562 ( Fig. 1b-d , Table S3 ). This 1200 nt region representing 10 % of the entire SBV genome contained 53 % (27/51) of the substitutions between the Na1 and Na2 Thus, the sequence comparison between SBV samples Na1 and Na2 revealed a high level of genomic variability between the two SBV-infected CNS samples obtained from within the same sheep herd. More differences were found between these two ovine samples than between each ovine sample and the prototype BH80/11-4 cattle sample. However, Na1 and Na2 shared ten common mutations within different genomic segments, showing the relatedness of these two ovine samples. In addition, this analysis of genome variability led to the identification of an HVR within the N terminus of the predicted Gc protein (corresponding to aa 457-847 of the M polyprotein). The functionality of this HVR in the context of SBV quasispecies evolution remains to be determined. This region corresponds to a variable ectodomain of the Gc protein exposed in the virion envelope of the related Bunyamwera virus (Shi et al., 2009) . Different HVRs involved in virus evolution have been reported previously in several RNA viruses. For example, the HVR of the calicivirus capsid protein has been shown to play an important role in antigenicity and receptor interactions in both human and animal caliciviruses (Chakravarty et al., 2005; Neill et al., 2000; Seal et al., 1993) .
The impact of cell-culture isolation and successive in vitro passages was next investigated to see whether the SBV sheep isolates Na1 and Na2 showed phenotypic and genetic adaptation. In order to address this question, virus isolation was performed from SBV-infected brain tissues of Na1 and Na2, containing high levels of SBV genomic copies, as detected by real-time quantitative reverse transcription-PCR (qRT-PCR) : the nervous systems of the two animals tested had cycle threshold values of 15.3 and 19.6, respectively. In order to obtain viral isolates, samples of 500 mg homogenized tissue were suspended in cell-culture medium. Serial dilutions (1 : 2-1 : 8) of the tissue suspensions were incubated with baby hamster kidney (BHK-21) cells for virus isolation. The inoculum was removed after 3 h and replaced with Glasgow minimum essential medium. At the second passage (P2), cell cultures inoculated with SBV qRT-PCR-positive brain tissues showed several plaques compatible with a viral cytopathic effect. Amplification of SBV was confirmed by testing the culture supernatants collected on two consecutive days by qRT-PCR. Viral stocks were prepared from P3 of the two viral isolates. Successive passages were performed for each isolate by infecting freshly prepared BHK-21 monolayers with the previous infectious supernatant titrated and diluted to an m.o.i. of 0.001 at each passage.
In order to characterize the growth properties of the viral isolates, the evolution of individual viral titres was assessed during successive BHK-21 passages (P2, P3, P6, P10, P15 and 20) (Fig. 2a) . Na1 infectious titres showed a two-step increase with a 2 log increase between P2 and P3, and a 1 log increase between P10 and P15. Na2 infectious titres showed an earlier increase and reached a plateau at passage 6. Phenotype characterization was completed by plaque size assays to examine the ability to produce viral plaques according to the number of passages (P3, P6, P10 and P20). In order to determine the relevance of the differences in plaque size, 50 randomly selected plaques were analysed using ImageJ software (http://rsb.info.nih.gov/ij/) at different passages (P3, P6, P10 and P20) for SBV isolates Na1 (Fig. 2b) and Na2 (Fig. 2c) . A wide range of plaque sizes was observed within each viral population, suggesting that quasi-species existed in the different tested situations. An adapted statistical method was used to take into account these variations and the actual distribution (Hollander & Wolfe, 1973) . To this end, data were analysed using the Kolmogorov-Smirnov test statistic, as described previously (Mathijs et al., 2010; Muylkens et al., 2006; Pasieka et al., 2003) . Significant enlargement of plaque sizes was observed during successive passages for the two isolates but not at the same passage. Viral plaques induced by the Na1 isolate showed significant differences between P3 and P6 (P50.0003) and between P10 and P20 (P,0.0001) (Fig.  2b) . For Na2, a significant difference in the enlargement of plaque sizes was only observed between P3 and P6 (P,0.0001), whereas differences between P6 and P10 and between P10 and P20 showed P values of 0.068 and 0.092, respectively (Fig. 2c) . Thus, the pattern of plaque sizes induced by Na1 and Na2 according to BHK-21 passages corroborated with the evolution of their viral titres. Indeed, a two-step increase was observed for Na1 through plaque size and viral titre assays (Fig. 2a, b) . In addition, Na2 cellculture adaptation was rapidly detected in the two assays and showed no significant increase after P6 (Fig. 2a, c) .
The phenotypic adaptation observed for Na1 and Na2 was analysed further by comparing the full-genome sequences of Na1 and Na2 at different cell-culture passages (P2 and P10) Fig. 2 . Biological characterization of the two SBV isolates, Na1 and Na2, after successive BHK-21 passages. (a) Viral titres of the two Belgian SBV isolates at specific BHK-21 passages. Titres (TCID 50 ) were determined after P2, P3, P6, P10, P15 and P20. (b, c) Evolution of plaque sizes of Na1 (b) and Na2 (c) was compared at specific cellular passages (P3, P6, P10 and P20) using the Kolmogorov-Smirnov test statistic. From a total of 50 randomly selected plaques measured at each passage, the cumulative percentage of plaques within increasing surface area ranges was calculated. Data were plotted as the surface area of plaque size against the cumulative percentage. Differences observed during cellular passages were compared (e.g. P3 vs P6, P6 vs P10 and P10 vs P20) by calculating the maximum absolute difference between the cumulative percentages of the two passages. P values were used to determine the level of significance between the compared populations. Significant differences are represented by up/down arrows marked with an asterisk, corresponding to P,0.0005. AU, Arbitrary units.
and a partial sequence of the M segment corresponding to the previously identified HVR (fragments M2 and M3; Fig. 1a) at P20 with the corresponding original CNS sequences. For characterization of the in vitro genomic variability, total RNA was extracted from infectious supernatant with a QIAmp Viral RNA kit (Qiagen). cDNA synthesis, PCR analysis and sequencing were performed as described above (see Table S2 for GenBank accession numbers).
Comparison with the original sample sequences showed accumulation of mutations at P2 and P10 with different profiles between Na1 and Na2 (Fig. 3) . Indeed, whereas four mutations were detected in the cell-adapted Na1 (three at P2 and one at P10), 20 mutations were found in the cell-adapted Na2 (11 at P2, eight at P10 and one at P20). Although the in vitro mutation rate differed between Na1 and Na2, the mutations were distributed non-randomly. As observed for the CNS samples, most of the additional mutations were detected in the HVR of the M segment. Indeed, among the four mutations observed for Na1, three were located in the HVR (Fig. 3a) . In the same way, ten of the 19 mutations observed for Na2 observed at P2 and P10 were also found in the HVR (Fig.  3b) . Interestingly, a common mutation shared by the celladapted Na1 and Na2 was identified at position 2562 of the M segment. Altogether, these data indicated that mutation accumulation occurred during in vitro adaptation of SBV within the N terminus of the Gc protein. This in vitro accumulation was detected in the absence of immune selective pressure, as is the case during in vivo infection and SBV spread in the animal population.
In conclusion, analysis of two SBV sheep isolates obtained from the same herd in Belgium revealed a high level of variability of this newly identified virus. One salient finding was that the SBV Gc protein contained an N-terminal domain that accumulated mutations in the natural course of SBV infection within a sheep herd and during BHK-21 adaptation. This result suggests that the variability identified in this domain may support different biological processes such as an immune evasion mechanism in the natural context of infection and/or adaptation of celltropism and cell-replication properties both in vivo and in vitro. Given that SBV re-emergence occurs even in regions with a high seroprevalence (Claine et al., 2013) , it will be interesting to investigate the impact of these alternative functions as a driving force for SBV evolution.
